<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ghislanzoni S</submitter><funding>Italian Ministry of Public Health</funding><funding>European Union's Horizon 2020 research and innovation program</funding><pagination>2678</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12823619</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(1)</volume><pubmed_abstract>Despite advances in cancer therapies, treatment failure from resistance and recurrence remains a major clinical challenge. Therapy-induced senescence (TIS), a state of stable cell cycle arrest with sustained metabolic activity, has emerged as a driver of inflammation, tumor persistence, and relapse. However, the heterogeneity of TIS complicates its detection and targeting. Here, we applied a multi-modal strategy to characterize metabolic alterations in senescent cancer cells induced by doxorubicin or γ-irradiation across three tumor cell lines: MCF7, HeLa, and TPC-1. Mitochondrial dysfunction was assessed using MitoTracker and JC-1 staining, while two-photon excitation fluorescence (TPEF) microscopy enabled label-free visualization of intracellular NAD(P)H and FAD distribution. Lipid remod</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Metabolic profiling of therapy-induced senescent cancer cells via TPEF, MALDI-MS, and RNA-sequencing.</pubmed_title><pmcid>PMC12823619</pmcid><funding_grant_id>101016923</funding_grant_id><funding_grant_id>RF 2019-12370456</funding_grant_id><pubmed_authors>Belfiore A</pubmed_authors><pubmed_authors>Niero M</pubmed_authors><pubmed_authors>Betti S</pubmed_authors><pubmed_authors>Torelli S</pubmed_authors><pubmed_authors>Bresci A</pubmed_authors><pubmed_authors>Bongarzone I</pubmed_authors><pubmed_authors>Bertolotti A</pubmed_authors><pubmed_authors>Ghislanzoni S</pubmed_authors><pubmed_authors>Padelli F</pubmed_authors><pubmed_authors>Agnelli L</pubmed_authors><pubmed_authors>Masella A</pubmed_authors><pubmed_authors>Polli D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Metabolic profiling of therapy-induced senescent cancer cells via TPEF, MALDI-MS, and RNA-sequencing.</name><description>Despite advances in cancer therapies, treatment failure from resistance and recurrence remains a major clinical challenge. Therapy-induced senescence (TIS), a state of stable cell cycle arrest with sustained metabolic activity, has emerged as a driver of inflammation, tumor persistence, and relapse. However, the heterogeneity of TIS complicates its detection and targeting. Here, we applied a multi-modal strategy to characterize metabolic alterations in senescent cancer cells induced by doxorubicin or γ-irradiation across three tumor cell lines: MCF7, HeLa, and TPC-1. Mitochondrial dysfunction was assessed using MitoTracker and JC-1 staining, while two-photon excitation fluorescence (TPEF) microscopy enabled label-free visualization of intracellular NAD(P)H and FAD distribution. Lipid remod</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-13T05:03:00.063Z</modification><creation>2026-06-13T03:08:40.193Z</creation></dates><accession>S-EPMC12823619</accession><cross_references><pubmed>41408108</pubmed><doi>10.1038/s41598-025-32573-y</doi></cross_references></HashMap>